The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Nuzolvence
zoliflodacin · ZOLIFLODACIN 3 g/1 · For Suspension · Oral · La Jolla Pharmaceutical Company
NDC 68547-0915-10 · 1 PACKET in 1 CARTON / 1 FOR SUSPENSION in 1 PACKET · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA219491
- TE code
- —
- Approval date
- Dec 12, 2025
- Patents / exclusivity
- 6 patents, 2 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | GAIN | Dec 12, 2035 |
| exclusivity | NCE | Dec 12, 2030 |
| patent | 9187495 | Jan 21, 2034 |
| patent | 9839641 | Jan 21, 2034 |
| patent | 8889671 | Jan 21, 2034 |
| patent | 9540394 | Jan 21, 2034 |
| patent | 8658641 | Jun 20, 2030 |
| patent | 9040528 | Oct 13, 2029 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of zoliflodacin (For Suspension)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| La Jolla Pharmaceutical Company | ZOLIFLODACIN 3 g/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Nuzolvence — NDC 68547-0915-10," retrieved September 3, 2026, https://drugdashboards.com/drug/68547091510.
Free to cite with attribution — see how the data is put together.